Health In Tech (HIT) has a market capitalization of approximately $63M, trading at
Health In Tech's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 3.1x. Valuation multiples are best compared with Technology sector peers rather than read in isolation.
Health In Tech runs a net profit margin of -2.4%, a gross margin of 58.9%, and an operating margin of -3.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Health In Tech reported revenue of
Health In Tech does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Health In Tech carries a debt-to-equity ratio of 0.01x and a current ratio of 3.13x, with a market beta of 2.89. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Health In Tech (HIT) the key facts are: market cap $63M, revenue
Get Health In Tech's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.